<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://bsms.arphahub.com/nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">126</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:7099c1e0-efdc-54e4-93b7-b6ecd3612deb</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Bulgarian Society of Medical Sciences Journal</journal-title>
        <abbrev-journal-title xml:lang="en">BSMS</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2815-4959</issn>
      <issn pub-type="epub">3033-1471</issn>
      <publisher>
        <publisher-name>Bulgarian Society of Medical Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/bsms.7.168566</article-id>
      <article-id pub-id-type="publisher-id">168566</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Therapeutics</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>﻿Exercise performance in fontan patients – a single-center Bulgarian study</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Simeonov</surname>
            <given-names>Lyudmil</given-names>
          </name>
          <email xlink:type="simple">lyudmilsimeonov@yahoo.com</email>
          <uri content-type="orcid">https://orcid.org/0000-0002-1853-9739</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Pechilkov</surname>
            <given-names>Dimitar</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-9734-0479</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Ivanova</surname>
            <given-names>Elena</given-names>
          </name>
          <email xlink:type="simple">elena.ivanova.leny@gmail.com</email>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Kaneva-Nencheva</surname>
            <given-names>Anna</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0001-7902-5494</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Department of Pediatric Cardiology, National Heart Hospital, Sofia, Bulgaria</addr-line>
        <institution>National Heart Hospital</institution>
        <addr-line content-type="city">Sofia</addr-line>
        <country>Bulgaria</country>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line content-type="verbatim">Department of Pediatric Anesthesiology and Intensive Care, UMHATEM N. I. Pirogov, Sofia, Bulgaria</addr-line>
        <institution>UMHATEM N. I. Pirogov</institution>
        <addr-line content-type="city">Sofia</addr-line>
        <country>Bulgaria</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Lyudmil Simeonov, Department of Pediatric Cardiology, National Heart Hospital, Sofia, Bulgaria; E-mail: <email xlink:type="simple">lyudmilsimeonov@yahoo.com</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2025</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>e168566</elocation-id>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/8225FDA6-E5DA-5F2F-9061-672E47F5D2B8">8225FDA6-E5DA-5F2F-9061-672E47F5D2B8</uri>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>08</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>10</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Lyudmil Simeonov, Dimitar Pechilkov, Elena Ivanova, Anna Kaneva-Nencheva</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>﻿Abstract</label>
        <p><bold>Aim</bold>: Exercise capacity in Fontan patients is reduced compared to healthy peers and progressive decline in cardiovascular function is expected over time. The purpose of this study is to present, analyze and discuss the initial Bulgarian experience with exercise performance of Fontan patients and to compare them to age-matched healthy peers. Additionally, we focused on understanding whether peak oxygen consumption can be predicted based on multiple independent variables.</p>
        <p><bold>Materials and methods</bold>: The research is a retrospective observational study of 11 patients aged 8y-18y, who had undergone the Fontan procedure and underwent cardiopulmonary exercise testing in National Heart Hospital in Sofia, Bulgaria. Data were collected for a 1-year period. Simultaneously, 11 age-matched healthy patients were selected for comparison.</p>
        <p><bold>Results</bold>: Patients with Fontan palliation had lower peak oxygen consumption (23.1 ml/kg/min vs. 30.1 ml/kg/min, P=0.046), percent-predicted peak oxygen consumption (52% vs. 76%, P&lt;0. 001), percent-predicted peak work (56% vs. 82%, P&lt;0.001), percent-predicted peak oxygen consumption at ventilatory anaerobic threshold (37% vs. 48%, P=0.04), resting saturation (93% vs. 97%, P&lt;0.001) and saturation at peak work (84% vs. 95%, P&lt;0.001). Male subjects and patients with left ventricular dominance exhibited a greater peak oxygen consumption.</p>
        <p><bold>Conclusion</bold>: Exercise capacity in the Bulgarian Fontan cohort is reduced relative to healthy controls. Male gender and subjects with left ventricular dominance have a greater peak oxygen consumption.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>Cardiopulmonary exercise testing</kwd>
        <kwd>exercise performance</kwd>
        <kwd>fontan procedure</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="﻿Introduction" id="SECID0EHE">
      <title>﻿Introduction</title>
      <p>The Fontan operation is the last of series of operations for a group of congenital cardiovascular anomalies in which it is not possible to maintain two-ventricle physiology <sup>[<xref ref-type="bibr" rid="B1 B2">1–2</xref>]</sup>. The procedure results in separating the systemic and pulmonary circulation by creating a total cavo-pulmonary connection <sup>[<xref ref-type="bibr" rid="B3 B4">3–4</xref>]</sup>. Pulmonary blood flow in Fontan circulation is passive and its adequacy depends on low impedance to passively forward flow and to lower pulmonary vascular resistance (<abbrev xlink:title="pulmonary vascular resistance" id="ABBRID0E2E">PVR</abbrev>). This newly constructed system is characterized by elevated central venous pressure and chronically low cardiac output (Fig. <xref ref-type="fig" rid="F1">1</xref>) <sup>[<xref ref-type="bibr" rid="B3">3</xref>]</sup>. Long term sequelae of the Fontan physiology is progressive decline in cardiovascular function <sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup>.</p>
      <fig id="F1" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/bsms.7.168566.figure1</object-id>
        <object-id content-type="arpha">D9504F4B-FBE2-54FD-B8FE-C0135F42A52F</object-id>
        <label>Figure 1.</label>
        <caption>
          <p>Schematic image of Fontane Procedure <sup>[<xref ref-type="bibr" rid="B3">3</xref>]</sup>.</p>
        </caption>
        <graphic xlink:href="bsms-07-001_article-168566__-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1455171.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/1455171</uri>
        </graphic>
      </fig>
      <p>Deterioration of cardiovascular efficiency leads to reduced exercise capacity. Contributing factors to exercise impairment include failure to increase stroke volume, chronotropic incompetence and reduced arterial blood saturation. Cardiopulmonary exercise testing (<abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0ETF">CPET</abbrev>) has an important role in the management of patients after Fontan operation. Peak oxygen uptake (peak VO<sub>2</sub>) is a significant index of exercise capacity and has a prognostic value in patients with congenital heart disease <sup>[<xref ref-type="bibr" rid="B6">6</xref>]</sup>. Patients after Fontan procedure have percent predicted peak VO<sub>2</sub> from 60–65% <sup>[<xref ref-type="bibr" rid="B7 B8">7–8</xref>]</sup>. Fernandes et al. reports that the hazard for death for patients with peak VO<sub>2</sub> less than 16.6 ml/kg/min was 7.5 times higher, compared to patients with higher peak VO<sub>2</sub><sup>[<xref ref-type="bibr" rid="B9">9</xref>]</sup>. Worsening of peak VO<sub>2</sub> over time predicts poorer outcomes including death, transplant, and unscheduled cardiac-related rehospitalization <sup>[<xref ref-type="bibr" rid="B10 B11">10–11</xref>]</sup>.</p>
      <p>The purpose of this study was to present the initial Bulgarian experience with exercise performance of Fontan patients and compare them to their healthy peers. This paper also focuses on understanding whether peak VO<sub>2</sub> can be predicted based on multiple independent variables.</p>
    </sec>
    <sec sec-type="materials|methods" id="SECID0EBH">
      <title>﻿Materials and methods</title>
      <sec sec-type="﻿Patient characteristics" id="SECID0EFH">
        <title>﻿Patient characteristics</title>
        <p>A retrospective observational study was conducted in Fontan patients referred to the Pediatric Cardiology Department in National Heart Hospital in Sofia, Bulgaria. This is the only center in the country involved in the surgical treatment of congenital heart defects. Patients aged 8y-18y with functionally univentricular heart who had undergone the Fontan procedure and had <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0ELH">CPET</abbrev> were investigated. Exclusion criteria from the study were patients less than 8 or above 18 years of age and a submaximal effort test. Data were collected over a one-year period, from August 2021 to August 2022, involving the patients that met the inclusion criteria (11 out of 19 patients). Simultaneously, 11 age-matched healthy patients from outpatient visits were selected for comparison. Additional factors assessed included ventricular morphology (right, left), ventricular dysfunction and more than moderate atrioventricular valve regurgitation, evaluated by echocardiography. The Ethics Committee in our institution approved the study protocol and waived the need for patient consent due to the study’s retrospective nature.</p>
      </sec>
      <sec sec-type="﻿Primary and secondary outcomes" id="SECID0EPH">
        <title>﻿Primary and secondary outcomes</title>
        <p>The authors reviewed patients’ medical files for baseline characteristics and anatomic details. We defined the primary outcome of interest: peak VO<sub>2</sub>, a direct measurement of cardiorespiratory fitness <sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup>. Secondary outcomes included peak work rate, peak heart rate, peak oxygen pulse, oxygen consumption (VO<sub>2</sub>) at ventilatory anaerobic threshold (<abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0EBAAC">VAT</abbrev>), minute ventilation/carbon dioxide production slope (VE/VCO<sub>2</sub> slope) at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0EHAAC">VAT</abbrev>, oxygen saturation at rest and at peak exercise. Peak VO<sub>2</sub>, VO<sub>2</sub> at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0EPAAC">VAT</abbrev>, work rate and heart rate are also expressed as a percentage of predicted normal values in order to eliminate sex, height and weight differences <sup>[<xref ref-type="bibr" rid="B13 B14">13–14</xref>]</sup>.</p>
      </sec>
      <sec sec-type="﻿Echocardiography" id="SECID0E1AAC">
        <title>﻿Echocardiography</title>
        <p>Transthoracic echocardiography was performed using Philips Epic 7c ultrasound system with X5-1 transducer. We graded atrioventricular valve regurgitation (<abbrev xlink:title="atrioventricular valve regurgitation" id="ABBRID0EABAC">AVVR</abbrev>) according to the American Society of Echocardiography recommended criteria: none to trivial, 0; mild, 1; mild to moderate, 2; moderate to severe, 3; and severe, 4 <sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup>. Ventricular dysfunction was assessed by the modified Simpson method using 4 chamber frames at end systole and end diastole, and was classified as follows: mildly abnormal, 41–51%; moderately abnormal, 30–40%; severely abnormal, &lt;30% <sup>[<xref ref-type="bibr" rid="B16 B17">16–17</xref>]</sup>.</p>
      </sec>
      <sec sec-type="﻿Cardiopulmonary exercise testing" id="SECID0ESBAC">
        <title>﻿Cardiopulmonary exercise testing</title>
        <p>All patients underwent <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EYBAC">CPET</abbrev> on an electrically braked cycle ergometer (Lode Corival; Lode BV, Groningen, The Netherlands). Meanwhile, VO<sub>2</sub> was measured using a commercial, breath-by-breath gas analysis system (Ultima-CPX, MGC Diagnostics Corp., St. Paul, Minnesota). A RAMP protocol was used, in which the patient should maintain a pedaling speed of about 60/minute. After an initial warm-up period of 2–3 minutes, the pedal resistance is gradually increased at a rate, based on the patient’s age, weight, gender, and level of fitness so that they reach peak exertion in 8–12 minutes. Anaerobic threshold was calculated using the V-slope method (170029). Oxygen pulse - a surrogate for stroke volume - was measured by dividing absolute oxygen uptake by heart rate. Also, VE/VCO<sub>2</sub> slope was assessed at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0EACAC">VAT</abbrev>. Blood pressure was measured every 2 minutes with an automatic cuff and a 12-lead ECG was obtained throughout the whole exercise. A maximal effort test was defined as peak respiratory exchange ratio (<abbrev xlink:title="respiratory exchange ratio" id="ABBRID0EECAC">RER</abbrev>)³ 1.05.</p>
      </sec>
      <sec sec-type="﻿Statistical analysis" id="SECID0EICAC">
        <title>﻿Statistical analysis</title>
        <p>The authors used descriptive statistics to provide frequencies and percentages for categorical variables and medians, and interquartile ranges for continuous variables. We used the students t-test to compare variables between Fontan patients and healthy patients. Normality was checked based on the normal Q-Q plot and histogram. Gender, age at Fontan, age at <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EOCAC">CPET</abbrev>, ventricular dominance, pulmonary vasodilator therapy, more than moderate <abbrev xlink:title="atrioventricular valve regurgitation" id="ABBRID0ESCAC">AVVR</abbrev> and ventricular dysfunction were assessed for linearity with peak VO<sub>2</sub>. Out of the 7 independent variables only gender and ventricular dominance were significantly linearly related. A multiple regression was run to predict peak VO<sub>2</sub> from gender and ventricular dominance. A value of P£0.05 indicated statistical significance. We used IBM SPSS Statistics 24 (IBM Corp., Armonk, N.Y., USA) for statistical analysis.</p>
      </sec>
    </sec>
    <sec sec-type="﻿Results" id="SECID0E1CAC">
      <title>﻿Results</title>
      <sec sec-type="﻿Study group characteristics" id="SECID0E5CAC">
        <title>﻿Study group characteristics</title>
        <p>We had 19 Fontan patients who were referred to the Pediatric Cardiology Department in National Heart Hospital in Sofia, Bulgaria between August, 2021 and August, 2022. A total of 11 patients were included in the study, regarding the including criteria. Fontan patients’ characteristics are summarized in Table <xref ref-type="table" rid="T1">1</xref>.</p>
        <p>It is accurate to note that Only 1 patient (9.1%) had more than moderate <abbrev xlink:title="atrioventricular valve regurgitation" id="ABBRID0EKDAC">AVVR</abbrev> and none of the observed patients had neither moderate, nor severe ventricular dysfunction and this may explain the fairly preserved numbers compared to larger registries. Hereby, we should mention that low burden of ventricular dysfunction in this group might bias results toward better exercise outcomes.</p>
        <p>All of the single ventricle patients had an extracardiac Fontan procedure. Comparison between Fontan patients and healthy subjects is presented in Table <xref ref-type="table" rid="T2">2</xref>. Age at <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EUDAC">CPET</abbrev>, body mass index and gender distribution were similar between the two groups for the purposes of objectivity.</p>
        <table-wrap id="T1" position="float" orientation="portrait">
          <label>Table 1.</label>
          <caption>
            <p>Fontan patients’ characteristics.</p>
          </caption>
          <table id="TID0EDFAE" rules="all">
            <tbody>
              <tr>
                <th rowspan="1" colspan="1">Variable</th>
                <th rowspan="1" colspan="1">Fontan (N=11)</th>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Male (n, %)</td>
                <td rowspan="1" colspan="1">9 (82%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Body mass index (BMI), median (range)</td>
                <td rowspan="1" colspan="1">19.8 (15.1–22.6)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Age at <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EBBAE">CPET</abbrev> (years), median (range)</td>
                <td rowspan="1" colspan="1">17 (11–17.9)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="2">Diagnosis (n, %):</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Tricuspid atresia</td>
                <td rowspan="1" colspan="1">2 (18.2%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Pulmonary atresia/intact ventricular septum</td>
                <td rowspan="1" colspan="1">3 (27.3%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Double outlet right ventricle</td>
                <td rowspan="1" colspan="1">1 (9.1%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Complex transposition of the great arteries</td>
                <td rowspan="1" colspan="1">2 (18.2%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Double inlet left ventricle</td>
                <td rowspan="1" colspan="1">3 (27.3%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Dominant left ventricle (n, %)</td>
                <td rowspan="1" colspan="1">7 (63.6%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">More than moderate <abbrev xlink:title="atrioventricular valve regurgitation" id="ABBRID0E2CAE">AVVR</abbrev> (n, %)</td>
                <td rowspan="1" colspan="1">1 (9.1%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="2">Ventricular dysfunction (n, %)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Mild</td>
                <td rowspan="1" colspan="1">4 (36.4%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Moderate</td>
                <td rowspan="1" colspan="1">0</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• Severe</td>
                <td rowspan="1" colspan="1">0</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Age at Fontan completion (years), median (range)</td>
                <td rowspan="1" colspan="1">3.3 (2.9–4.8)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="2">Conduit size (n, %):</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• 16 mm</td>
                <td rowspan="1" colspan="1">3 (37.3%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• 18 mm</td>
                <td rowspan="1" colspan="1">6 (54.5%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• 19 mm</td>
                <td rowspan="1" colspan="1">1 (9.1%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">• 20 mm</td>
                <td rowspan="1" colspan="1">1 (9.1%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Fenestration (n, %)</td>
                <td rowspan="1" colspan="1">3 (27.3%)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Pulmonary vasodilator (n, %)</td>
                <td rowspan="1" colspan="1">4 (36.4%)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>* Abbreviations: <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EUFAE">CPET</abbrev> – cardiopulmonary exercise testing; <abbrev xlink:title="atrioventricular valve regurgitation" id="ABBRID0EYFAE">AVVR</abbrev> - atrioventricular valve regurgitation.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="T2" position="float" orientation="portrait">
          <label>Table 2.</label>
          <caption>
            <p>Comparison between Fontan and healthy patients.</p>
          </caption>
          <table id="TID0EDOAE" rules="all">
            <tbody>
              <tr>
                <th rowspan="1" colspan="1">Variable</th>
                <th rowspan="1" colspan="1">Healthy patients (N = 11)</th>
                <th rowspan="1" colspan="1">Fontan patients (N = 11)</th>
                <th rowspan="1" colspan="1">P</th>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Male (%)</td>
                <td rowspan="1" colspan="1">7 (63.6)</td>
                <td rowspan="1" colspan="1">9 (82)</td>
                <td rowspan="1" colspan="1">0.35</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Body mass index (BMI), median (range)</td>
                <td rowspan="1" colspan="1">19.3 (14.7–22.9)</td>
                <td rowspan="1" colspan="1">19.8 (15.1–22.6)</td>
                <td rowspan="1" colspan="1">0.89</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Age at <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EUHAE">CPET</abbrev> (years), median (range)</td>
                <td rowspan="1" colspan="1">14.1 (9.4–17.2)</td>
                <td rowspan="1" colspan="1">17 (11–17.9)</td>
                <td rowspan="1" colspan="1">0.13</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>* Abbreviations: <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EFIAE">CPET</abbrev> - cardiopulmonary exercise testing.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec sec-type="﻿Cardiopulmonary exercise testing parameters between the two groups" id="SECID0EYDAC">
        <title>﻿Cardiopulmonary exercise testing parameters between the two groups</title>
        <p>All of the study subjects achieved maximal effort test. Exercise capacity in our Fontan cohort was reduced compared to healthy peers - patients after Fontan palliation had lower peak VO<sub>2</sub> (23.1 ml/kg/min vs. 30.1 ml/kg/min, P=0.046), percent-predicted peak VO<sub>2</sub> (52% vs. 76%, P&lt;0.001), percent-predicted peak work (56% vs. 82%, P&lt;0.001), percent-predicted peak VO<sub>2</sub> at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0EEEAC">VAT</abbrev> (37% vs. 48%, P=0.04), resting saturation (93% vs. 97%, P&lt;0.001) and saturation at peak work (84% vs. 95%, P&lt;0.001). None of the patients exhibited ECG abnormalities and one Fontan patients had an abnormal blood pressure response. Comparison of <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EIEAC">CPET</abbrev> parameters between the two groups is demonstrated in Table <xref ref-type="table" rid="T3">3</xref>.</p>
        <table-wrap id="T3" position="float" orientation="portrait">
          <label>Table 3.</label>
          <caption>
            <p>Cardiopulmonary exercise testing parameters between the two groups.</p>
          </caption>
          <table id="TID0EXRAE" rules="all">
            <tbody>
              <tr>
                <th rowspan="2" colspan="1">Variables</th>
                <th rowspan="2" colspan="1">Healthy patients (N = 11)</th>
                <th rowspan="2" colspan="1">Fontan patients (N = 11)</th>
                <th rowspan="2" colspan="1">P</th>
                <th rowspan="2" colspan="1">Mean difference</th>
                <th rowspan="1" colspan="2">95% CI</th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1">LL</th>
                <th rowspan="1" colspan="1">UL</th>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Ramp protocol (W), median (range)</td>
                <td rowspan="1" colspan="1">15 (10–20)</td>
                <td rowspan="1" colspan="1">15 (10–20)</td>
                <td rowspan="1" colspan="1">0.71</td>
                <td rowspan="1" colspan="1">0.45</td>
                <td rowspan="1" colspan="1">-2.326</td>
                <td rowspan="1" colspan="1">3.235</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Peak work (W), median (range)</td>
                <td rowspan="1" colspan="1">126 (77–186)</td>
                <td rowspan="1" colspan="1">125 (45–189)</td>
                <td rowspan="1" colspan="1">0.51</td>
                <td rowspan="1" colspan="1">18.20</td>
                <td rowspan="1" colspan="1">-16.35</td>
                <td rowspan="1" colspan="1">52.71</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Percent-predicted peak work (%), median (range)</td>
                <td rowspan="1" colspan="1">82 (60–100)</td>
                <td rowspan="1" colspan="1">56 (27–75)</td>
                <td rowspan="1" colspan="1">&lt;0.001</td>
                <td rowspan="1" colspan="1">23.73</td>
                <td rowspan="1" colspan="1">11.632</td>
                <td rowspan="1" colspan="1">35.822</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Peak oxygen consumption (ml/kg/min), median (range)</td>
                <td rowspan="1" colspan="1">30.1 (19.4–42.3)</td>
                <td rowspan="1" colspan="1">23.1 (15.2–40.3)</td>
                <td rowspan="1" colspan="1">0.046</td>
                <td rowspan="1" colspan="1">5.73</td>
                <td rowspan="1" colspan="1">-0.589</td>
                <td rowspan="1" colspan="1">12.043</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Percent-predicted peak oxygen consumption (%), median (range)</td>
                <td rowspan="1" colspan="1">76 (65–100)</td>
                <td rowspan="1" colspan="1">52 (31–91)</td>
                <td rowspan="1" colspan="1">&lt;0.001</td>
                <td rowspan="1" colspan="1">27.20</td>
                <td rowspan="1" colspan="1">13.690</td>
                <td rowspan="1" colspan="1">40.672</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Peak <abbrev xlink:title="respiratory exchange ratio" id="ABBRID0ECNAE">RER</abbrev>, median (range)</td>
                <td rowspan="1" colspan="1">1.16 (1.05–1.51)</td>
                <td rowspan="1" colspan="1">1.24 (1.06–1.30)</td>
                <td rowspan="1" colspan="1">0.53</td>
                <td rowspan="1" colspan="1">-0.12</td>
                <td rowspan="1" colspan="1">-0.103</td>
                <td rowspan="1" colspan="1">0.101</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Peak oxygen pulse (%), median (range)</td>
                <td rowspan="1" colspan="1">86 (48–98)</td>
                <td rowspan="1" colspan="1">63 (53–108)</td>
                <td rowspan="1" colspan="1">0.21</td>
                <td rowspan="1" colspan="1">7.73</td>
                <td rowspan="1" colspan="1">-8.328</td>
                <td rowspan="1" colspan="1">23.783</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Peak heart rate (bpm), median (range)</td>
                <td rowspan="1" colspan="1">176 (149–195)</td>
                <td rowspan="1" colspan="1">162 (103–196)</td>
                <td rowspan="1" colspan="1">0.09</td>
                <td rowspan="1" colspan="1">16.10</td>
                <td rowspan="1" colspan="1">-2.625</td>
                <td rowspan="1" colspan="1">34.807</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Percent-predicted peak heart rate (%), median (range)</td>
                <td rowspan="1" colspan="1">84 (71–96)</td>
                <td rowspan="1" colspan="1">80 (49–96)</td>
                <td rowspan="1" colspan="1">0.12</td>
                <td rowspan="1" colspan="1">7.10</td>
                <td rowspan="1" colspan="1">-2.456</td>
                <td rowspan="1" colspan="1">16.638</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Percent-predicted peak oxygen consumption at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0E6PAE">VAT</abbrev> (%), median (range)</td>
                <td rowspan="1" colspan="1">48 (28–65)</td>
                <td rowspan="1" colspan="1">37 (25–60)</td>
                <td rowspan="1" colspan="1">0.04</td>
                <td rowspan="1" colspan="1">10.23</td>
                <td rowspan="1" colspan="1">0.385</td>
                <td rowspan="1" colspan="1">20.069</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">VE/VCO<sub>2</sub> at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0E3QAE">VAT</abbrev>, median (range)</td>
                <td rowspan="1" colspan="1">28 (25–31)</td>
                <td rowspan="1" colspan="1">32 (21–41)</td>
                <td rowspan="1" colspan="1">0.14</td>
                <td rowspan="1" colspan="1">-3.10</td>
                <td rowspan="1" colspan="1">-7.083</td>
                <td rowspan="1" colspan="1">0.901</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Resting saturation (%), median (range)</td>
                <td rowspan="1" colspan="1">97 (96–99)</td>
                <td rowspan="1" colspan="1">93 (78–96)</td>
                <td rowspan="1" colspan="1">&lt;0.0001</td>
                <td rowspan="1" colspan="1">6.45</td>
                <td rowspan="1" colspan="1">2.800</td>
                <td rowspan="1" colspan="1">10.108</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Saturation at peak exercise (%), median (range)</td>
                <td rowspan="1" colspan="1">95 (93–98)</td>
                <td rowspan="1" colspan="1">84 (70–94)</td>
                <td rowspan="1" colspan="1">&lt;0.0001</td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">5.433</td>
                <td rowspan="1" colspan="1">14.566</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">ECG abnormalities</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0.98</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">-0.872</td>
                <td rowspan="1" colspan="1">0.145</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Abnormal blood pressure response</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">1</td>
                <td rowspan="1" colspan="1">0.32</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">-0.090</td>
                <td rowspan="1" colspan="1">0.281</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>* Abbreviations: <abbrev xlink:title="respiratory exchange ratio" id="ABBRID0EOUAE">RER</abbrev> - respiratory exchange ratio; <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0ESUAE">VAT</abbrev> - ventilatory anaerobic threshold; VE/VECO<sub>2</sub> - ratio of minute ventilation to carbon dioxide production; LL - lower limit; UL - upper limit; p – statistical significance.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec sec-type="﻿Predicting peak oxygen consumption" id="SECID0EQEAC">
        <title>﻿Predicting peak oxygen consumption</title>
        <p>A multiple regression was run to predict peak VO<sub>2</sub> from gender and ventricular dominance. The multiple regression model statistically significantly predicted peak VO<sub>2</sub>, F (2, 8) = 12.998, P = 0.003, adj. R2= .71. Both gender and ventricular dominance added statistically significantly to the prediction, P=0.003. Male Fontan patients exhibited higher peak VO<sub>2</sub> of 11.925 ml/kg/min. Peak VO<sub>2</sub> for patients with left ventricular dominance was 7.738 ml/kg/min, greater than patients with right ventricular dominance. Regression coefficients and standard errors can be found in Table <xref ref-type="table" rid="T4">4</xref>.</p>
        <table-wrap id="T4" position="float" orientation="portrait">
          <label>Table 4.</label>
          <caption>
            <p>Multiple regression results for peak oxygen consumption.</p>
          </caption>
          <table id="TID0EFDAG" rules="all">
            <tbody>
              <tr>
                <th rowspan="2" colspan="1">Variables</th>
                <th rowspan="2" colspan="1">B</th>
                <th rowspan="2" colspan="1">SE B</th>
                <th rowspan="2" colspan="1">P</th>
                <th rowspan="1" colspan="2">95% CI for B</th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1">LL</th>
                <th rowspan="1" colspan="1">UL</th>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Constant</td>
                <td rowspan="1" colspan="1">8.712</td>
                <td rowspan="1" colspan="1">3.394</td>
                <td rowspan="1" colspan="1">0.033</td>
                <td rowspan="1" colspan="1">0.886</td>
                <td rowspan="1" colspan="1">16.539</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Gender</td>
                <td rowspan="1" colspan="1">11.925</td>
                <td rowspan="1" colspan="1">2.936</td>
                <td rowspan="1" colspan="1">0.004</td>
                <td rowspan="1" colspan="1">4.925</td>
                <td rowspan="1" colspan="1">18.925</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Ventricular dominance</td>
                <td rowspan="1" colspan="1">7.738</td>
                <td rowspan="1" colspan="1">2.036</td>
                <td rowspan="1" colspan="1">0.005</td>
                <td rowspan="1" colspan="1">3.041</td>
                <td rowspan="1" colspan="1">12.434</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>* Abbreviations: B – unstandardized regression coefficient; SE B – standard error of the coefficient; CI – confidence interval; LL – lower limit; UL – upper limit; p – statistical significance.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec sec-type="﻿Discussion" id="SECID0ECFAC">
      <title>﻿Discussion</title>
      <p>Patients with functionally univentricular heart survive satisfactory into adulthood after Fontan completion <sup>[<xref ref-type="bibr" rid="B18 B19">18–19</xref>]</sup>. The creation of such an unconventional circulation results in improved exercise capacity compared to preoperative state, but it is still reduced in comparison with healthy subjects. Patients after the Fontan procedure are expected to have a decline in cardiovascular function over time with subsequent decrease in exercise performance <sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup>. This leads to poorer outcomes, including death, transplant, and unscheduled cardiac-related rehospitalization. <sup>[<xref ref-type="bibr" rid="B10 B11">10–11</xref>]</sup>.</p>
      <p>Cardiopulmonary exercise testing (<abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0E6FAC">CPET</abbrev>) is a crucial tool to objectively assess exercise performance and functional capacity in patients with congenital heart disease. Access to <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EDGAC">CPET</abbrev> in Bulgaria is not routine and scarce experience has been gained in recent years. This method provides objective data for assessing functional limitations, tracking disease progression, and guiding personalized treatment strategies. By monitoring objective metrics over time, <abbrev xlink:title="Cardiopulmonary exercise testing" id="ABBRID0EHGAC">CPET</abbrev> helps tailor exercise prescriptions, optimize timing for interventions, identify early signs of complications, and guides the creation of personalized, safe exercise programs to improve long-term outcomes.</p>
      <p>This study documents that in practice, exercise capacity in Bulgarian Fontan patients is reduced compared to healthy peers. The performed multiple regression analysis reveals that male patients and patients with left ventricular dominance have a greater peak VO<sub>2</sub>.</p>
      <p>We demonstrated that peak VO<sub>2</sub>, as well as VO<sub>2</sub> at <abbrev xlink:title="ventilatory anaerobic threshold" id="ABBRID0EVGAC">VAT</abbrev> and percent-predicted peak work vary significantly between Fontan patients and healthy subjects. These finding extend those of others <sup>[<xref ref-type="bibr" rid="B7 B8">7–8</xref>, <xref ref-type="bibr" rid="B20 B21 B22">20–22</xref>]</sup>, confirming that exercise capacity is impaired in Fontan patients. Known causes of depressed exercise function may include: inability to increase stroke volume normally in response to exercise; chronotropic incompetence; arterial desaturation; pulmonary abnormalities; deconditioning <sup>[<xref ref-type="bibr" rid="B23">23</xref>]</sup>. Interestingly, peak oxygen pulse, percent-predicted peak heart rate and VE/VCO<sub>2</sub> slope were similar between the two studied groups.</p>
      <p>In accordance with previous findings <sup>[<xref ref-type="bibr" rid="B24 B25 B26 B27 B28">24–28</xref>]</sup>, anatomic morphology may be associated with difference in exercise performance. Fontan patients with left ventricular dominance had greater peak VO<sub>2</sub> than patients with right ventricular dominance. It would seem reasonable that a systemic right ventricle would less likely adapt to hemodynamic changes, leading to progressive decline in cardiovascular function and exercise intolerance. Dominant right ventricle morphology is associated with poorer outcomes on a long-term follow up <sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup>.</p>
      <p>There are limited data on patients with Fontan physiology regarding exercise parameter difference between males and females. Seckeler and colleagues previously reported that peak VO<sub>2</sub> decreased by 32% through adolescence in females and did not have the typical increase for adolescence for males <sup>[<xref ref-type="bibr" rid="B30">30</xref>]</sup>. Our study reveals that male patients have a higher peak VO<sub>2</sub>.</p>
      <sec sec-type="﻿Study limitations" id="SECID0EDIAC">
        <title>﻿Study limitations</title>
        <p>Some limitations are worth noting. A RAMP protocol was used via cycle ergometer, which means that obtained peak VO<sub>2</sub> is lower than uphill treadmill running. Cycle ergometry was used mainly because of the relatively young patients age. Another limitation is the single-center, retrospective, non-randomized design of the study. Also, the small sample size in this research may limit the ability to observe significant differences.</p>
      </sec>
    </sec>
    <sec sec-type="﻿Conclusion" id="SECID0ELIAC">
      <title>﻿Conclusion</title>
      <p>Cardiopulmonary exercise testing has an important role in management of patients after Fontan operation. Our current data on the topic provide the first description of exercise capacity in Bulgarian Fontan patients. Our initial experience revealed that patients after the Fontan procedure have impaired exercise performance compared to healthy peers. Male gender and left ventricular dominance are associated with greater peak VO<sub>2</sub>. These findings address the need for serial cardiopulmonary exercise testing in Fontan patients to monitor for declining peak oxygen consumption. Future multicenter collaborations with larger Fontan cohorts are needed for better understanding exercise capacity trajectories and identifing factors associated with outcomes over time.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="﻿Additional information" id="SECID0EUIAC">
      <title>﻿Additional information</title>
      <p>
        <bold>Conflict of interest</bold>
      </p>
      <p>The authors have declared that no competing interests exist.</p>
      <p>
        <bold>Ethical statements</bold>
      </p>
      <p>The authors declared that no clinical trials were used in the present study.</p>
      <p>The authors declared that no experiments on humans or human tissues were performed for the present study.</p>
      <p>The authors declared that no informed consent was obtained from the humans, donors or donors’ representatives participating in the study.</p>
      <p>The authors declared that no experiments on animals were performed for the present study.</p>
      <p>The authors declared that no commercially available immortalised human and animal cell lines were used in the present study.</p>
      <p>
        <bold>Use of AI</bold>
      </p>
      <p>No use of AI was reported.</p>
      <p>
        <bold>Funding</bold>
      </p>
      <p>No funding was reported.</p>
      <p>
        <bold>Author contributions</bold>
      </p>
      <p>All authors have contributed equally.</p>
      <p>
        <bold>Author ORCIDs</bold>
      </p>
      <p>Lyudmil Simeonov ￼ <ext-link xlink:href="https://orcid.org/0000-0002-1853-9739" ext-link-type="uri" xlink:type="simple">https://orcid.org/0000-0002-1853-9739</ext-link></p>
      <p>Dimitar Pechilkov ￼ <ext-link xlink:href="https://orcid.org/0000-0002-9734-0479" ext-link-type="uri" xlink:type="simple">https://orcid.org/0000-0002-9734-0479</ext-link></p>
      <p>Anna Kaneva-Nencheva ￼ <ext-link xlink:href="https://orcid.org/0000-0001-7902-5494" ext-link-type="uri" xlink:type="simple">https://orcid.org/0000-0001-7902-5494</ext-link></p>
      <p>
        <bold>Data availability</bold>
      </p>
      <p>All of the data that support the findings of this study are available in the main text or Supplementary Information.</p>
    </sec>
    <ref-list>
      <title>﻿References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation xlink:type="simple">Jacobs JP, Maruszewski B. Functionally univentricular heart and the Fontan operation: lessons learned about patterns of practice and outcomes from the congenital heart surgery databases of the European association for cardio-thoracic surgery and the society of thoracic surgeons. World J Pediatr Congenit Heart Surg. 2013;4(4):349–355.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation xlink:type="simple">Wilkinson JL, Anderson RH. Anatomy of functionally single ventricle. World J Pediatr Congenit Heart Surg. 2012;3(2):159–164.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation xlink:type="simple">Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240–248.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation xlink:type="simple">Kreutzer G, Galíndez E, Bono H, De Palma C, Laura JP. An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg. 1973;66(4):613–621.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation xlink:type="simple">Atz AM, Zak V, Mahony L, et al. Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure. J Am Coll Cardiol. 2017;69(22):2735–2744.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation xlink:type="simple">Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112(6):828–835.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation xlink:type="simple">Müller J, Christov F, Schreiber C, Hess J, Hager A. Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection. Eur Heart J. 2009;30(23):2915–2920.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation xlink:type="simple">Paridon SM, Mitchell PD, Colan SD, et al. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008;52(2):99–107.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation xlink:type="simple">Fernandes SM, Alexander ME, Graham DA, et al. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery. Congenit Heart Dis. 2011;6(4):294–303.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation xlink:type="simple">Henaine R, Vergnat M, Bacha EA, et al. Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation. J Thorac Cardiovasc Surg. 2013;146(3):522–529.</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation xlink:type="simple">Khambadkone S, Li J, de Leval MR, Cullen S, Deanfield JE, Redington AN. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation. 2003;107(25):3204–3208.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation xlink:type="simple">Kokkinos P, Myers J. Exercise and physical activity: clinical outcomes and applications. Circulation. 2010;122(16):1637–1648.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation xlink:type="simple">Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985;131(5):700–708.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation xlink:type="simple">Jones NL. Clinical Exercise Testing. 3rd ed. Philadelphia: Saunders 1988.</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation xlink:type="simple">Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802.</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation xlink:type="simple">Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14.</mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation xlink:type="simple">Gaskill SE, Ruby BC, Walker AJ, Sanchez OA, Serfass RC, Leon AS. Validity and reliability of combining three methods to determine ventilatory threshold. Med Sci Sports Exerc. 2001;33(11):1841–1848.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation xlink:type="simple">d’Udekem Y, Iyengar AJ, Galati JC, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation. 2014;130(11 Suppl 1):S32–S38.</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation xlink:type="simple">Cordina R, du Plessis K, Tran D, d’Udekem Y. Super-Fontan: Is it possible?. J Thorac Cardiovasc Surg. 2018;155(3):1192–1194.</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation xlink:type="simple">Terol Espinosa de Los Monteros C, Harteveld LM, Kuipers IM, et al. Prognostic Value of Maximal and Submaximal Exercise Performance in Fontan Patients &lt; 15 Years of Age. Am J Cardiol. 2021;154:92–98.</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation xlink:type="simple">Harteveld LM, Blom NA, Terol Espinosa de Los Monteros C, et al. Determinants of exercise limitation in contemporary paediatric Fontan patients with an extra cardiac conduit. Int J Cardiol. 2021;341:31–38.</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation xlink:type="simple">Inuzuka R, Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125(2):250–259.</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation xlink:type="simple">Opotowsky AR, Allen KY, Bucholz EM, et al. Pediatric and Congenital Cardiovascular Disease Research Challenges and Opportunities: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;80(23):2239–2250.</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation xlink:type="simple">Goldberg DJ, Zak V, McCrindle BW, et al. Exercise Capacity and Predictors of Performance After Fontan: Results from the Pediatric Heart Network Fontan 3 Study. Pediatr Cardiol. 2021;42(1):158–168.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation xlink:type="simple">Weinreb SJ, Dodds KM, Burstein DS, et al. End-Organ Function and Exercise Performance in Patients With Fontan Circulation: What Characterizes the High Performers?. J Am Heart Assoc. 2020;9(24):e016850.</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation xlink:type="simple">Ohuchi H, Yasuda K, Hasegawa S, et al. Influence of ventricular morphology on aerobic exercise capacity in patients after the Fontan operation. J Am Coll Cardiol. 2001;37(7):1967–1974.</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation xlink:type="simple">Giardini A, Hager A, Pace Napoleone C, Picchio FM. Natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann Thorac Surg. 2008;85(3):818–821.</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation xlink:type="simple">Tran DL, Celermajer DS, Ayer J, et al. The “Super-Fontan” Phenotype: Characterizing Factors Associated With High Physical Performance. Front Cardiovasc Med. 2021;8:764273.</mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation xlink:type="simple">Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85–92.</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation xlink:type="simple">Seckeler, M. D., Barber, B. J., Colombo, J. N., Bernardi, A. M., Hoyer, A. W., Andrews, J. G., &amp; Klewer, S. E. (2021). Exercise Performance in Adolescents With Fontan Physiology (from the Pediatric Heart Network Fontan Public Data Set). The American journal of cardiology, 149, 119–125.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
